which surpassed the Zacks Consensus Estimate of $570 million. In the year-ago quarter, total revenues were $439.7 million. The top line rose 35% year over year, mainly driven by increased product ...

Investors might want to bet on ViaSat (VSAT), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum ...

CleanSpark (CLSK) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since ...

The uptake for the product has been encouraging, with new patients starting treatment as well as several patients switching from Onpattro. Amvuttra sales beat the Zacks Consensus Estimate of $280 ...

It sounds like a variety of new Apple products are preparing to launch. That’s according to Bloomberg‘s Mark Gurman, who has shared more details tonight about what to expect and when.

(Reuters) -Sweden's SSAB posted fourth-quarter operating profit well above analysts' estimates on Wednesday, helped by resilient demand for its high-strength steel and other premium products ...

Feb 5 (Reuters) - Bio-Techne (TECH.O), opens new tab beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop ...

Engaging in high levels of physical activity can lead to a nine-year biological aging advantage, according to a study from Birgham Young University. Regular intensive exercise slows cellular aging ...

Adjusted EBITDA rose to $3.88 billion for Q4 2024, helped by an increase in transport volumes for petroleum and refined products ... missed the Zacks Consensus Estimate by 19.4 percent.